Which patients with sentinel node-positive breast cancer after breast conservation still receive completion axillary lymph node dissection in routine clinical practice?

被引:0
|
作者
André Hennigs
Melitta Köpke
Manuel Feißt
Fabian Riedel
Mahdi Rezai
Ulrike Nitz
Mareike Moderow
Michael Golatta
Christof Sohn
Andreas Schneeweiss
Jörg Heil
机构
[1] University of Heidelberg,Department of Gynecology and Obstetrics
[2] University of Heidelberg,Institute of Medical Biometry and Informatics
[3] Luisen Hospital,European Breast Center
[4] Evangelical Hospital Johanniter Bethesda,National Center for Tumor Diseases
[5] Breast Center Niederrhein,undefined
[6] West German Breast Center Ltd,undefined
[7] University of Heidelberg,undefined
来源
Breast Cancer Research and Treatment | 2019年 / 173卷
关键词
Breast cancer; Axillary lymph node dissection; Mastectomy; ACOSOG Z0011; Time-tend analysis; Sentinel lymph node dissection; Tumour-involved sentinel lymph node;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:429 / 438
页数:9
相关论文
共 50 条
  • [31] Sentinel lymph node dissection provides axillary control equal to complete axillary node dissection in breast cancer patients with lobular histology and a negative sentinel node
    Khakpour, N
    Hunt, KK
    Kuerer, HM
    Yi, M
    Meric-Bernstam, F
    Ross, MI
    Lucci, A
    AMERICAN JOURNAL OF SURGERY, 2005, 190 (04) : 598 - 601
  • [32] Axillary dissection in sentinel lymph node positive breast cancer: Is the staging information worthwhile for patients?
    Chang, David W.
    Bressel, Mathias
    Hansen, Carmen
    Blinman, Prunella
    Schofield, Penelope
    Chua, Boon H.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 (02) : E27 - E34
  • [33] Sentinel lymph node biopsy alone without axillary lymph node dissection - follow up of sentinel lymph node negative breast cancer patients
    Reitsamer, R
    Peintinger, F
    Prokop, E
    Menzel, C
    Cimpoca, W
    Rettenbacher, L
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2003, 29 (03): : 221 - 223
  • [34] Axillary lymph node dissection in node-positive breast cancer: are ten nodes adequate and when is enough, enough?
    Laura H. Rosenberger
    Yi Ren
    Samantha M. Thomas
    Rachel A. Greenup
    Oluwadamilola M. Fayanju
    E. Shelley Hwang
    Jennifer K. Plichta
    Breast Cancer Research and Treatment, 2020, 179 : 661 - 670
  • [35] Axillary lymph node dissection in node-positive breast cancer: are ten nodes adequate and when is enough, enough?
    Rosenberger, Laura H.
    Ren, Yi
    Thomas, Samantha M.
    Greenup, Rachel A.
    Fayanju, Oluwadamilola M.
    Hwang, E. Shelley
    Plichta, Jennifer K.
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 179 (03) : 661 - 670
  • [36] The role of sentinal lymph node biopsy in determining the need for completion axillary node dissection after neoadjuvant chemotherapy in patients with lymph node positive breast cancer
    Khan, A
    Sabel, M
    Diehl, K
    Schott, A
    Cimmino, V
    Chang, A
    Kleer, C
    Newman, LA
    ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (02) : S102 - S102
  • [37] The role of sentinal lymph node biopsy in determining the need for completion axillary node dissection after neoadjuvant chemotherapy in patients with lymph node positive breast cancer
    A. Khan
    M. Sabel
    K. Diehl
    A. Schott
    V. Cimmino
    A. Chang
    C. Kleer
    L. A. Newman
    Annals of Surgical Oncology, 2004, 11 : S102 - S102
  • [38] Outcome of Selected Breast Cancer Patients With Micrometastasis or Isolated Tumor Cells in Sentinel Node Biopsy and No Completion Axillary Lymph Node Dissection
    Meretoja, Tuomo J.
    Vironen, Jaana H.
    Heikkila, Paivi S.
    Leidenius, Marjut H.
    JOURNAL OF SURGICAL ONCOLOGY, 2010, 102 (03) : 215 - 219
  • [39] Prevalence and Consequences of Axillary Lymph Node Dissection in the Era of Sentinel Lymph Node Biopsy for Breast Cancer
    Yen, Tina W. F.
    Laud, Purushottam W.
    Pezzin, Liliana E.
    McGinley, Emily L.
    Wozniak, Erica
    Sparapani, Rodney
    Nattinger, Ann B.
    MEDICAL CARE, 2018, 56 (01) : 78 - 84
  • [40] Is axillary dissection needed in node-positive breast cancer.?
    Greenberg, Caprice C.
    Bafford, Andrea C.
    Golshan, Mehra
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (02) : 195 - 198